Simris Group is a biotech company, engaged in research, development and production of bioactive substances from cyanobacteria and microalgae for pharmaceutical applications.
At Simris, we are pioneering the next generation of ADC payloads to revolutionise cancer treatment. Our platform is built on the world’s largest cyanobacterial strain library and over two decades of deep scientific expertise.
Through our proprietary discovery and bioconjugation technologies, we are developing novel, IP-protected payloads with the potential to dramatically improve both the efficacy and safety of ADC therapeutics.
Our headquarters are located in Hammenhög, Sweden. Simris Group AB is a public company and our stock is traded on the Nasdaq First North stock exchange (FNSE:SIMRIS B).
http://www.simrisgroup.com
http://www.simrisbiologics.com
Company Details
- Employees
- 6
- Founded
- -
- Address
- Herrestadsvägen 24a, Hammenhög,skåne 276 50,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.simrisgroup.com
- Keywords
- algae, microalgae, biotech, drug discovery, ADC Payloads, Cyanobacteria, licence opportunities, anti-aging, Anti-boady Drug Conjugates, Microcystins.
- HQ
- Hammenhög, Skåne
Simris Group Ab Questions
Simris Group Ab's website is http://www.simrisgroup.com
Simris Group Ab's LinkedIn profile is https://se.linkedin.com/company/simrisgroup
Simris Group Ab has
6 employees.
View email and phone details for 6
employees at Simris Group Ab.
Simris Group Ab's industry is
Biotechnology Research
Simris Group Ab's top competitors are
Algaspring,
Catxalot Seaweed Adventures,
Volta Greentech,
Algiecel,
Swedish Algae Factory,
Alganelle,
The Algae Factory™,
Nordic Seafarm,
Simris Biologics,
Doro Group.
Simris Group Ab's categories are Biotechnology Research
Simris Group Ab's founding year is 2011
